Omega-3 vs Omega-6
Omega-3 vs Omega-6: Key Benefits for Your Heart and Health Imagine you’re shopping in the…
Omega-3 vs Omega-6
Omega-3 vs Omega-6: Key Benefits for Your Heart and Health Imagine you’re shopping in the grocery store, looking at different cooking oils. Some labels say “omega-3” or “omega-6,” and you wonder what they mean. Maybe your doctor has mentioned them before, but you’re not sure how they affect your health. Don’t worry, I’ll help you!…
Hospital M&A Has Hit the Brakes — But Activity Could Pick Up in the Second Half of 2025
Hospital M&A activity slowed quite a bit in the first half of 2025, with deal volume and transacted revenue falling sharply amid economic uncertainty and sweeping policy changes. While traditional mergers may remain sluggish, analysts expect a rise in outpatient partnerships and rural hospital conversions toward the end of the year. The post Hospital M&A…
The Trump Administration’s Foreign Aid Review: Status of U.S. Support for CEPI
Fact sheet examining actions taken by the Trump administration and their impact on Gavi.
Medicare at 60: A Popular Program Facing Challenges
In this article in the Journal of Health Politics, Policy and Law, KFF’s Tricia Neuman, Jeannie Fuglesten Biniek and Juliette Cubanski examine three isssues facing Medicare’s future: privatization, affordability and spending/financing.
KFF Health News’ ‘What the Health?’: Digesting Trump’s Big Budget Law
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma
AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile. The post AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma appeared first…
Why CMS/AHIP’s prior authorization changes won’t hurt payers.
Myself and Kristy Piccinini, PhD from FTI Consulting published a new commentary in The Evidence Base titled “Perspectives from the Healthcare Economist: Why CMS/AHIP’s prior authorization changes won’t hurt payers.” Dr. Shafrin and Dr. Piccinini share their insights in this Guest Column examining the implications of recent CMS/AHIP prior authorization reforms and why these changes are unlikely…
6 Aesthetic Certification Programs That Include Both Theory and Practical Training
[Sponsored] Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice. The post 6 Aesthetic Certification Programs That Include Both Theory and Practical Training appeared first on MedCity News.
Rethinking Masculinity in Men’s Health
Too many men ignore symptoms until they can no longer function. We end up seeing them in the emergency room, sometimes with late-stage cancer or uncontrolled chronic disease that could have been managed if addressed earlier. The post Rethinking Masculinity in Men’s Health appeared first on MedCity News.
Access to OB-GYNs: Evaluating Workforce Supply and ACA Marketplace Networks
This brief examines the supply of OB-GYNs in the U.S. and the share of OB-GYNs participating in the provider networks of Qualified Health Plans (QHPs) offered in the individual market in the federal and state Affordable Care Act (ACA) Marketplaces in 2021.
